以下文章来源于投资家 ，作者云帆 投资家 . 投资家是投资家网旗下专注创投、商业、科技领域的内容平台。多次获得百度、头条、新浪、网易、搜 狐、东财、同花顺、澎湃等颁发的荣誉奖项。投资家网是国内知名资本与产业创新综合服务平台。 作者： 云帆 来源： 投资家 这家炮制骗局的 A 股上市公司，妄想谎言梦碎前，狠狠坑一波股民。最近，靠一支"童颜针"火遍 医美界的吴中美学关联母公司江苏吴中（ *ST 苏吴）连续五日涨停后，突然停牌。监管查出， *ST 苏吴长期造假、掏空资产，性质恶劣，随即对其启动重大违法强制退市措施 。 值得一提的是，两个月前，吴中美学还在社交平台"伸张正义"，发布"关于高举法律武器维护自身 合法权益的严正宣告"。 彼时，"吴中美学与医美龙头爱美客及韩国子公司 Regen ，就医美产品 AestheFill 的中国境内独 家经销权发生纠纷。"这件事在医美界闹得沸沸扬扬，也使吴中美学备受外界关注。 吴中美学曾发文称，"人无信不立，业无信不兴。"指责" Regen 公司恶意违约，随意践踏契约精 神。"爱美客卷入风波，股价暴跌，被外界喷的体无完肤。谁都没想到，两个月后风云莫测，"医美 界最大黑马"江苏吴中成 ...

Group 1 - In May 2025, the number of newly registered private equity and venture capital fund managers in China dropped to 2, a decrease of 83.3% compared to April and a 60% decline year-on-year [1] - A total of 339 new private equity and venture capital funds were registered, marking a year-on-year increase of 55.5% but a month-on-month decrease of 18.7% [1] - The domestic primary equity investment market recorded 428 financing events, representing a year-on-year decrease of 13.6% and a month-on-month decrease of 18.0% [1] Group 2 - Shenzhen Innovation Investment Group (Deep Venture) has registered a new fund, the Shenzhen Hongtu Seed Fund, with a total capital contribution of 300 million yuan, focusing on advanced technology sectors [2] - The Shenzhen Semiconductor and Integrated Circuit Industry Investment Fund aims for a total scale of 5 billion yuan, with 3.6 billion yuan already contributed by various local government funds [3] Group 3 - Deep Venture disclosed 10 equity investment events in the reporting period, a fivefold increase compared to May 2024 and a 66.7% increase from April [3] - In the first five months of 2025, Deep Venture made 43 investments, which is 58.1% of its total investments in 2024 [3] Group 4 - 60% of Deep Venture's projects in May were in the angel and A-round early stages, with a focus on advanced manufacturing, particularly in integrated circuits and aerospace [6] - The company invested in "Sailu Medical," which completed an A+ round of financing, with funds aimed at expanding its sequencing platform and global market outreach [11][12]